[Infusion treatment in shock].
Nowadays, above all dextran, gelatin and starch solutions are available for the infusion theraphy of the various forms of shock. The application of these volume substitutes must be strictly controlled to avoid in particular cardial and pulmonal commplications. Blood transfusion combined with a volume substitute should only be applied in cases of heavy loss of blood. The treatment of metabolic acidose which usually occurs simultaneously is carried out with an alkaline solution.
D000138:Acidosis / Q000628:therapy; D000468:Alkalies / Q000627:therapeutic use; D000707:Anaphylaxis / Q000628:therapy; D003911:Dextrans / Q000627:therapeutic use; D004837:Epinephrine / Q000627:therapeutic use; D005780:Gelatin / Q000627:therapeutic use; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006801:Humans; D007263:Infusions, Parenteral; D009638:Norepinephrine / Q000627:therapeutic use; D010952:Plasma Substitutes / Q000008:administration & dosage*; D012769:Shock / Q000628:therapy*; D012770:Shock, Cardiogenic / Q000628:therapy; D012771:Shock, Hemorrhagic / Q000628:therapy; D012772:Shock, Septic / Q000628:therapy; D013213:Starch / Q000627:therapeutic use; D014662:Vasoconstrictor Agents / Q000627:therapeutic use
D000468:Alkalies; D003911:Dextrans; D006634:Histamine H1 Antagonists; D010952:Plasma Substitutes; D014662:Vasoconstrictor Agents; D005780:Gelatin; D013213:Starch; D009638:Norepinephrine; D004837:Epinephrine
Infusionsbehandlung beim Schock